BARCELONA – As more regulatory professionals adopt artificial intelligence (AI) tools as part of their jobs, a panel of experts who spoke at the RAPS AI in Regulatory Conference advised attendees to ...

The US Food and Drug Administration (FDA) has issued draft guidance to assist sponsors in developing early-phase first-in-human (FIH) studies for investigational drugs and biologics aimed at treating ...